Expression, Clinical Significance, Immune Infiltration, and Regulation Network of MiR-3940-5p in Lung Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2022 Aug 15

PMID 35966511

Authors

Zhichao Lin

Wenhai Huang

Zehua Xie

Yongsheng Yi

Zumei Li

Affiliations

Soon will be listed here.

Abstract

Background: Based on bioinformatics analysis and experimental validation, we investigated the expression, clinical significance, immune infiltration, and potential signaling pathways of miR-3940-5p in lung adenocarcinoma (LUAD).

Methods: 521 LUAD tissue samples and 46 normal lung tissue samples from The Cancer Genome Atlas (TCGA) database. We evaluated the relationship between clinical features and miR-3940-5p expression using Kruskal-Wallis, Wilcoxon sign-rank, and logistic regression, explored the relationship between miR-3940-5p expression and the prognosis of LUAD patients using Kaplan-Meier survival curve analysis. Several databases were used to identify miRNA targets. MiR-3940-5p target genes were analyzed based on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. The significant role of miR-3940-5p in function was evaluated using immune infiltration analysis. LUAD cell lines were tested for miR-3940-5p expression using QRT-PCR.

Results: There was a significant association between high miR-3940-5p expression in LUAD and T stage (P=0.005), pathologic stage (P=0.047), race (White vs Asian & Black or African American) (P=0.041), residual tumor (P=0.043), and anatomic neoplasm subdivision2 (P=0.030). MiR-3940-5p expression predicted poor overall survival (HR: 1.35; 95% CI: 1.01-1.81; P=0.045), disease-specific survival (HR: 1.53; 95% CI: 1.05-2.23; P=0.026), and progression-free survival (HR: 1.35; 95% CI: 1.03-1.77; P=0.032). BAP1, BBS1, CCR2, KCNE3, PEBP1, and RABL2A were all associated with poor OS in LUAD patients with low miR-3940-5p expression levels. According to GO and KEGG analyses, miR-3940-5p may play a role in LUAD development by regulating pathways such as measles, PI3K-Akt signaling pathway, and p53 signaling pathway. There was a correlation between the expression level of miR-3940-5p and immune infiltration. LUAD cell lines showed significantly higher levels of miR-3940-5p than Beas-2B cells.

Conclusion: A high expression of miR-3940-5p is significantly associated with a poor prognosis in patients with LUAD, suggesting that it could be used as a prognostic biomarker.

Citing Articles

Unveiling the Enigmatic Role of SLC35F3 in Lung Adenocarcinoma.

Ye Y, Long F, Yue W, Wei Z, Yang J, Xie Y Clin Respir J. 2024; 18(10):e70023.

PMID: 39414367 PMC: 11483511. DOI: 10.1111/crj.70023.

High TLX1 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Lung Adenocarcinoma.

Zhao L, Zheng H, Chen F, Lu H, Yu Q, Yan X Curr Mol Med. 2023; 24(6):801-812.

PMID: 37340746 DOI: 10.2174/1566524023666230619123752.

Development and Validation of a Prognostic Nomogram for Lung Adenocarcinoma: A Population-Based Study.

Xie B, Chen X, Deng Q, Shi K, Xiao J, Zou Y J Healthc Eng. 2022; 2022:5698582.

PMID: 36536690 PMC: 9759395. DOI: 10.1155/2022/5698582.

References

Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

Wang J, Jia Y, Zhao S, Zhang X, Wang X, Han X . BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer. Oncogene. 2017; 36(45):6235-6243. DOI: 10.1038/onc.2017.217. View

Zhou M, Chen X, Bai H, Sun Y, Zhang Z, Li S . RABL2A-CCDC34 Axis Promotes Sorafenib Resistance in Hepatocellular Carcinoma. DNA Cell Biol. 2021; 40(11):1418-1427. DOI: 10.1089/dna.2021.0473. View

Switlik W, Karbownik M, Suwalski M, Kozak J, Szemraj J . Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study. Genet Test Mol Biomarkers. 2019; 23(5):353-358. DOI: 10.1089/gtmb.2018.0275. View

Vavougios G, Solenov E, Hatzoglou C, Baturina G, Katkova L, Molyvdas P . Computational genomic analysis of PARK7 interactome reveals high BBS1 gene expression as a prognostic factor favoring survival in malignant pleural mesothelioma. Am J Physiol Lung Cell Mol Physiol. 2015; 309(7):L677-86. DOI: 10.1152/ajplung.00051.2015. View

Chen B, Jin X, Wang H, Zhou Q, Li G, Lu X . Expression, Clinical Significance, and Prospective Pathway Signaling of miR-501-3p in Ovarian Cancer Based on Database and Informatics Analysis. Int J Gen Med. 2021; 14:5193-5201. PMC: 8423717. DOI: 10.2147/IJGM.S327673. View

Gan T, Chen W, Qin H, Huang S, Yang L, Fang Y . Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis. Med Sci Monit. 2017; 23:2453-2464. PMC: 5448611. DOI: 10.12659/msm.901460. View

Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf A . Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013; 39(4):782-95. DOI: 10.1016/j.immuni.2013.10.003. View

Hanzelmann S, Castelo R, Guinney J . GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013; 14:7. PMC: 3618321. DOI: 10.1186/1471-2105-14-7. View

10.

Lin S, Gregory R . MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015; 15(6):321-33. PMC: 4859809. DOI: 10.1038/nrc3932. View

11.

Lu X, Li G, Liu S, Wang H, Chen B . MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer. J Ovarian Res. 2021; 14(1):90. PMC: 8268593. DOI: 10.1186/s13048-021-00841-w. View

12.

Xin G, Cao X, Zhao W, Lv P, Qiu G, Li Y . MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma. Math Biosci Eng. 2020; 17(6):8074-8083. DOI: 10.3934/mbe.2020409. View

13.

Lu X, Jing L, Liu S, Wang H, Chen B . miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma. Int J Endocrinol. 2022; 2022:5006123. PMC: 9200575. DOI: 10.1155/2022/5006123. View

14.

Wang S, Zhao X, Wang J, Wen Y, Zhang L, Wang D . Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer. Med Oncol. 2013; 30(3):681. DOI: 10.1007/s12032-013-0681-x. View

15.

Rupaimoole R, Calin G, Lopez-Berestein G, Sood A . miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discov. 2016; 6(3):235-46. PMC: 4783232. DOI: 10.1158/2159-8290.CD-15-0893. View

16.

Vosa U, Vooder T, Kolde R, Fischer K, Valk K, Tonisson N . Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer. 2011; 50(10):812-22. DOI: 10.1002/gcc.20902. View

17.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

18.

Schmall A, Al-Tamari H, Herold S, Kampschulte M, Weigert A, Wietelmann A . Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer. Am J Respir Crit Care Med. 2014; 191(4):437-47. DOI: 10.1164/rccm.201406-1137OC. View

19.

Xu J, Zhang Z, Qian M, Wang S, Qiu W, Chen Z . Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation. J Exp Clin Cancer Res. 2020; 39(1):59. PMC: 7132976. DOI: 10.1186/s13046-020-01553-7. View

20.

Gu W, Fang S, Gao L, Tan Y, Yang Z . Clinic significance of microRNA-99a expression in human lung adenocarcinoma. J Surg Oncol. 2013; 108(4):248-55. DOI: 10.1002/jso.23381. View